| Fecha | Trimestre | Sesión | BPA (est → real) | Ingresos (est → reales) |
|---|---|---|---|---|
| 28 oct 2026Próximo | Q3 2026 | Tras el cierre | 3,63 | 6,73 B |
1 sept 2026
Stryker (NYSE:SYK) received FDA De Novo authorization for its SportSuite Vision software on Apple Vision Pro in a clinical setting. The company reported completion of the first surgical procedure using SportSuite Vision in an operating room environment. The software introduces augmented reality and spatial computing tools into surgical workflows and operating room visualization. The authorization marks a regulatory milestone for Stryker in mixed reality applications for healthcare. This...
Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.
SYK's planned ZuriMED acquisition adds the FiberLocker System, aiming to strengthen its shoulder portfolio and rotator cuff care capabilities.
Stryker (NYSE: SYK), a global leader in medical technologies, announced today that the first surgical procedure using SportSuite Vision on Apple Vision Pro was successfully completed at Duke Health. SportSuite Vision received FDA De Novo authorization on July 17, making it the first application authorized by the FDA for intraoperative use with Apple Vision Pro and marking a new milestone for spatial computing in the operating room.
Stryker has considerably underperformed the broader market over the past year, while analysts remain bullish on its future prospects.
Stryker (NYSE: SYK), a global leader in medical technologies, announced today that the first surgical procedure using SportSuite Vision on Apple Vision Pro was successfully completed at Duke Health. SportSuite Vision
Stryker stock has delivered a modest total return over the past five years, while the current intrinsic value estimate from a Discounted Cash Flow (DCF) framework suggests the shares trade at a discount to that internal calculation. At the same time, market based valuation multiples point to pricing that is broadly in line with peers, which leaves investors weighing two different valuation signals. Stryker has returned about 23.3% over the past five years, which points to a measured long...
31 ago 2026
Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach for rotator cuff augmentation designed for increased biomechanical strength.The acquisition strengthens Stryker’s shoulder portfolio, enhancing its ability to support specialists across the continuum of care.The FiberLocker System is a soft tissue augmentation technology designed to red
28 ago 2026
PBH vs. SYK: Which Stock Is the Better Value Option?
27 ago 2026
Portage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations. About Str
26 ago 2026
Investors need to pay close attention to SYK stock based on the movements in the options market lately.
21 ago 2026
Stryker’s sales unit in Michigan previously secured a US$100.00 million contract modification from the U.S. Defense Logistics Agency, underscoring its role as a key supplier to government healthcare and logistics systems. This award highlights the importance of stable government contracting as a complement to Stryker’s hospital and surgical product revenue mix. We’ll now examine how this sizable Defense Logistics Agency contract influences Stryker’s investment narrative, particularly its...
SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.
Stryker (SYK) is back in focus after its Stryker Sales unit secured a $100 million contract modification from the US Defense Logistics Agency, a development that coincided with a 2.7% share price move. See our latest analysis for Stryker. For context, Stryker’s share price has been volatile around recent news, with a 4.17% 1 month share price return and a 5.88% decline year to date, while the 1 year total shareholder return is down 13.98%, the 3 year total shareholder return is up 23.40%, and...
Ronda E Stryker, Board Member at Stryker (NYSE:SYK), reported an insider sell on August 20, according to a new SEC filing. What Happened: After conducting a thorough analysis, Stryker sold 350,000 shares of Stryker.
